Cytek Biosciences, Inc. (CTKB) vs Wave Life Sciences Ltd. (WVE)

A side-by-side comparison of Cytek Biosciences, Inc. and Wave Life Sciences Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CTKB vs WVE

growth of $100 · dividends reinvested · last 5y
CTKB -67.5% (-20.1%/yr)WVE -45.3% (-11.4%/yr)WVE compounded faster over this window
0100200Start $10020222023202420252026$32$55
CTKB WVE

CTKB vs WVE: by the numbers

  • •CTKB is the larger company ($695M vs $691M market cap).
  • •Both run net losses; CTKB's is the smaller (-38.98% vs -309.73% net margin).
  • •WVE grew revenue faster over the past five years (33.08% vs 13.37% CAGR).

Metrics side by side

Valuation

MetricCTKBWVE
P/S ratio3.3610.57
P/B ratio2.161.52

Profitability

MetricCTKBWVE
Gross margin53.23%79.28%
Operating margin-21.60%-504.09%
Net margin-38.98%-309.73%
ROE-25.03%-44.64%
ROIC-12.00%-42.94%

Growth (annualized)

MetricCTKBWVE
Revenue CAGR (5Y)13.37%33.08%
Total return CAGR (5Y)-23.16%-4.33%

Frequently asked

Which has grown faster, CTKB or WVE?
Over the past five years, WVE grew revenue faster — CTKB at a 13.37% CAGR versus WVE at 33.08%.
How have CTKB and WVE total returns compared?
Over the past 5 years, CTKB delivered -23.16% and WVE delivered -4.33% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.